$ZS

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

Original reporting
Published Oct 7, 2026, 5:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 6:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ZS
Neutral
medium confidence
Mentioned
$ZS
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ZSNeutralMed
01

Why it matters

Guidance could shift valuation multiples; analysts' divergent price targets reflect uncertainty.

02

Market read

Zscaler's new ARR goal is the primary new fact, influencing its valuation and sector peers.

03

What to watch

Insider selling and negative profit margins could weigh more heavily than the long‑term ARR goal.

Relevance 7/10Novelty 7/10Timing: today

Background

Zscaler's Investor Day revealed a strategic growth target amid mixed analyst commentary and insider sell‑off.

Company-level read

Ticker impact

$ZSNeutralMedium confidence
Context

Zscaler announced a new $8B organic ARR target for FY2031, the first public disclosure of this long‑term guidance.

Expected impact

potential modest downside as investors price in lower near‑term target, but upside upside if growth materializes.

Evidence & confidence

Guidance is new but far‑term; analyst split suggests limited immediate price move.

Market effects

Sets a higher ARR benchmark for the cloud‑security sector, may pressure peers to raise guidance.

Limited to US tech investors; no broader regional effect.

Modest, as Zscaler is a notable player in global SASE market.

Counterpoint

The ARR target may be overly optimistic given competitive pressures; investors could short on the downside.

Key entities

  • Morgan Stanley

    Maintained Equal-weight rating, lowered price target to $185.

  • UBS

    Raised price target to $250, maintained Buy rating.

Related articles

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.

$ZSHigh

RBC Capital maintains Zscaler stock rating on $8B ARR target

RBC Capital reiterated an Outperform rating and $236.00 price target on Zscaler (ZS) after the company's Investor Day, where it set an $8B ARR target for 2031. The stock trades at $210.94, and analysts have raised earnings estimates. Several firms increased price targets, with Cantor Fitzgerald setting the highest at $275.